---
figid: PMC3730126__nihms492735f1
figlink: /pmc/articles/PMC3730126/figure/F1/
number: Figure 1
caption: Molecular mechanisms of cellular insulin resistance in muscle and liver.
  Increased intracellular diacyglycerols lead to activation of PKC-θ and PKC-ε in
  skeletal muscle and liver, respectively, which, in turn, decreases insulin-stimulated
  IRS-1/IRS-2 tyrosine phosphorylation, PI3K activation and downstream insulin signaling.
  (a) In the muscle, this results in decreased muscle glycogen synthesis, owing to
  reduced insulin-stimulated GLUT4 translocation to the plasma membrane. (b) In the
  liver, this results in decreased hepatic glycogen synthesis, owing to decreased
  activation of glycogen synthase, and increased hepatic gluconeogenesis. The use
  of transgenic and knockout mice, as well as antisense oligonucleotides to knock
  down specific proteins, has allowed the validation of the diacylglycerol-mediated
  insulin hypothesis of insulin resistance through the manipulation of key proteins
  in the pathway. KO, knockout; GLUT4, glucose transporter type 4; TAG, triacylglycerol;
  LPL, lipoproteinlipase; Tg, transgenic; FATP-1, fatty acid transport protein-1;
  DGAT, diacylglycerol O-acyltransferase; UCP3, uncoupling protein-3; GS, glycogen
  synthase; LCAD, long-chain acyl-CoA dehydrogenase; mtGPAT, mitochondrial glycerol-3-phosphate
  acyltransferase; ASO, antisense oligonucleotide.
pmcid: PMC3730126
papertitle: Diacylglycerol-mediated insulin resistance.
reftext: Derek M Erion, et al. Nat Med. ;16(4):400-402.
pmc_ranked_result_index: '62191'
pathway_score: 0.9243089
filename: nihms492735f1.jpg
figtitle: Molecular mechanisms of cellular insulin resistance in muscle and liver
year: ''
organisms: Homo sapiens
ndex: 75a221f2-df0d-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3730126__nihms492735f1.html
  '@type': Dataset
  description: Molecular mechanisms of cellular insulin resistance in muscle and liver.
    Increased intracellular diacyglycerols lead to activation of PKC-θ and PKC-ε in
    skeletal muscle and liver, respectively, which, in turn, decreases insulin-stimulated
    IRS-1/IRS-2 tyrosine phosphorylation, PI3K activation and downstream insulin signaling.
    (a) In the muscle, this results in decreased muscle glycogen synthesis, owing
    to reduced insulin-stimulated GLUT4 translocation to the plasma membrane. (b)
    In the liver, this results in decreased hepatic glycogen synthesis, owing to decreased
    activation of glycogen synthase, and increased hepatic gluconeogenesis. The use
    of transgenic and knockout mice, as well as antisense oligonucleotides to knock
    down specific proteins, has allowed the validation of the diacylglycerol-mediated
    insulin hypothesis of insulin resistance through the manipulation of key proteins
    in the pathway. KO, knockout; GLUT4, glucose transporter type 4; TAG, triacylglycerol;
    LPL, lipoproteinlipase; Tg, transgenic; FATP-1, fatty acid transport protein-1;
    DGAT, diacylglycerol O-acyltransferase; UCP3, uncoupling protein-3; GS, glycogen
    synthase; LCAD, long-chain acyl-CoA dehydrogenase; mtGPAT, mitochondrial glycerol-3-phosphate
    acyltransferase; ASO, antisense oligonucleotide.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRS2
  - PIK3CA
  - IRS1
  - GNAS
  - PIK3R4
  - PIK3R3
  - LPL
  - SLC2A4
  - CALD1
  - PIK3R5
  - GNAL
  - ACACA
  - PIK3R6
  - TG
  - PIK3CG
  - SLC27A1
  - ACACB
  - UCP3
  - PIK3CD
  - DGAT1
  - DGAT2
  - PIK3CB
  - BCL2A1
  - Glucose
  - glucose
  - serine
  - tyrosine
genes:
- word: IRS-2
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: GS
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAS
  entrez: '2778'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: LPL
  symbol: LPL
  source: hgnc_symbol
  hgnc_symbol: LPL
  entrez: '4023'
- word: GLUT4
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
- word: LCAD
  symbol: L-CAD
  source: hgnc_alias_symbol
  hgnc_symbol: CALD1
  entrez: '800'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: GS
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAL
  entrez: '2774'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Tg
  symbol: TG
  source: hgnc_symbol
  hgnc_symbol: TG
  entrez: '7038'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: FATP-1
  symbol: FATP1
  source: hgnc_alias_symbol
  hgnc_symbol: SLC27A1
  entrez: '376497'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: UCP3
  symbol: UCP3
  source: hgnc_symbol
  hgnc_symbol: UCP3
  entrez: '7352'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: DGAT-1
  symbol: DGAT1
  source: hgnc_symbol
  hgnc_symbol: DGAT1
  entrez: '8694'
- word: DGAT-2
  symbol: DGAT2
  source: hgnc_symbol
  hgnc_symbol: DGAT2
  entrez: '84649'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: ACC2
  symbol: ACC-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2A1
  entrez: '597'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
- word: glucose
  source: MESH
  identifier: D005947
- word: serine
  source: MESH
  identifier: D012694
- word: tyrosine
  source: MESH
  identifier: D014443
diseases: []
---
